miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways

International Journal of Oncology

Volumn 44, Issue 5, 2014, Pages 1571-1580

  Liu, Zhenlin ^a   Jiang, Zhongmin ^a   Huang, Jianyong ^b   Huang, Shuqiang ^b   Li, Yanxia ^a   Yu, Simiao ^a   Yu, Shizhu ^c,d   Liu, Xiaozhi ^a,b  

^a TIANJIN FIFTH CENTRAL HOSPITAL   (China)

^b Duke University   (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Epidermal growth factor receptor; Glioma; MicroRNA 7; Phosphoinositide 3 kinase

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; MICRORNA; MICRORNA 7; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CANCER GROWTH; CELL CYCLE ARREST; CELL GROWTH; CELL INVASION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSIENT EXPRESSION; TRANSIENT TRANSFECTION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BRAIN; CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICRORNAS; NEOPLASMS, EXPERIMENTAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84899099255     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2322     Document Type: Article

References (41)

1. Raizer JJ, Grimm S, Chamberlain MC, et al: A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas. Cancer 116: 5297-5305, 2010.
2. Bonavia R, Inda MM, Cavenee WK and Furnari FB: Heterogeneity maintenance in glioblastoma: a social network. Cancer Res 71: 4055-4060, 2011.
3. Masica DL and Karchin R: Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res 71: 4550-4561, 2011.
4. Yang RY, Yang KS, Pike LJ and Marshall GR: Targeting the dimerization of epidermal growth factor receptors with small-molecule inhibitors. Chem Biol Drug Des 76: 1-9, 2010.
5. Tabunoki H, Saito N, Suwanborirux K, et al: Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids. Cancer Cell Int 12: 14, 2012.
6. Ivliev AE, 't Hoen PA and Sergeeva MG: Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma. Cancer Res 70: 10060-10070, 2010.
7. Rong Y, Belozerov VE, Tucker-Burden C, et al: Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. Cancer Res 69: 2540-2549, 2009.
8. Mazzoleni S, Politi LS, Pala M, et al: Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 70: 7500-7513, 2010.
9. Martinez I and Dimaio D: B-Myb, cancer, senescence, and microRNAs. Cancer Res 71: 5370-5373, 2011.
10. Ibrahim AF, Weirauch U, Thomas M, et al: MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 71: 5214-5224, 2011.
11. Farazi TA, Horlings HM, Ten Hoeve JJ, et al: MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 71: 4443-4453, 2011.
12. Liu N, Landreh M, Cao K, et al: The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482: 519-523, 2012.
13. Wu DG, Wang YY, Fan LG, et al: MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin Med J 124: 2616-2621, 2011.
14. Nguyen HT, Dalmasso G, Yan Y, et al: MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J Biol Chem 285: 1479-1489, 2010.
15. Reddy SD, Ohshiro K, Rayala SK and Kumar R: MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 68: 8195-8200, 2008.
16. Webster RJ, Giles KM, Price KJ, et al: Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 284: 5731-5741, 2009.
17. Xiong S, Zheng Y, Jiang P, et al: MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci 7: 805-814, 2011.
18. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
19. Hu BS, Tan JW, Zhu GH, et al: WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721. World J Gastroenterol 18: 3020-3026, 2012.
20. Yoo AS, Sun AX, Li L, et al: MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 476: 228-231, 2011.
21. Xiong F, Wu C, Chang J, et al: Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 71: 5175-5181, 2011.
22. Zhou X, Ren Y, Moore L, et al: Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 90: 144-155, 2010.
23. Dong H, Luo L, Hong S, et al: Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst Biol 4: 163, 2010.
24. Huang PH, Miraldi ER, Xu AM, et al: Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol Biosyst 6: 1227-1237, 2010.
25. Lal B, Goodwin CR, Sang Y, et al: EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Mol Cancer Ther 8: 1751-1760, 2009.
26. Reznik TE, Sang Y, Ma Y, et al: Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Mol Cancer Res 6: 139-150, 2008. (Pubitemid 351378174)
27. Huang PH, Cavenee WK, Furnari FB and White FM: Uncovering therapeutic targets for glioblastoma: a systems biology approach. Cell Cycle 6: 2750-2754, 2007. (Pubitemid 350277165)
28. Chou YT, Lin HH, Lien YC, et al: EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res 70: 8822-8831, 2010.
29. Kirubakaran P, Kothapalli R, Singh KhD, et al: In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme. Bioinformation 6: 100-106, 2011.
30. Kakkar A, Suri V, Jha P, et al: Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients. Neurol India 59: 254-261, 2011.
31. Halatsch ME, Löw S, Hielscher T, et al: Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib. Anticancer Res 28: 3725-3728, 2008.
32. Motomura K, Natsume A, Kishida Y, et al: Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: a multicenter study. Cancer 117: 1721-1730, 2011.
33. Griffero F, Daga A, Marubbi D, et al: Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J Biol Chem 284: 7138-7148, 2009.
34. Cesana M, Cacchiarelli D, Legnini I, et al: A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147: 358-369, 2011.
35. Patterson EE, Holloway AK, Weng J, et al: MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 117: 1630-1639, 2011.
36. Paroo Z, Ye X, Chen S and Liu Q: Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 139: 112-122, 2009.
37. Hide T, Takezaki T, Nakatani Y, et al: Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells. Stem Cells 29: 590-599, 2011.
38. Fu S and Kurzrock R: Development of curcumin as an epigenetic agent. Cancer 116: 4670-4676, 2010.
39. Zhu H, Acquaviva J, Ramachandran P, et al: Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proc Natl Acad Sci USA 106: 2712-2716, 2009.
40. Löw S, Vougioukas VI, Hielscher T, et al: Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinib. Anticancer Res 28: 3729-3732, 2008.
41. Kefas B, Godlewski J, Comeau L, et al: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566-3572, 2008.